Sundeep Dugar

2.5k total citations
70 papers, 1.9k citations indexed

About

Sundeep Dugar is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Sundeep Dugar has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 27 papers in Organic Chemistry and 10 papers in Cancer Research. Recurrent topics in Sundeep Dugar's work include Melanoma and MAPK Pathways (13 papers), Synthesis of β-Lactam Compounds (9 papers) and Synthesis and biological activity (8 papers). Sundeep Dugar is often cited by papers focused on Melanoma and MAPK Pathways (13 papers), Synthesis of β-Lactam Compounds (9 papers) and Synthesis and biological activity (8 papers). Sundeep Dugar collaborates with scholars based in United States, Mexico and New Zealand. Sundeep Dugar's co-authors include Sarvajit Chakravarty, Andrew A. Protter, Rebecca Miller, Linda S. Higgins, George F. Schreiner, Ann M. Kapoun, Alison Murphy, John W. Clader, Satyanarayana Medicherla and Michael Reiß and has published in prestigious journals such as The EMBO Journal, Blood and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Sundeep Dugar

67 papers receiving 1.8k citations

Peers

Sundeep Dugar
Mui Cheung United States
Ying Sun China
Xiaojing Shi China
Xiaohong Shu China
Mamoru Shoji United States
Si Chen China
Hao Xie United States
Mariano Redondo‐Horcajo Spain
Yhun Yhong Sheen South Korea
Allan S. Wagman United States
Mui Cheung United States
Sundeep Dugar
Citations per year, relative to Sundeep Dugar Sundeep Dugar (= 1×) peers Mui Cheung

Countries citing papers authored by Sundeep Dugar

Since Specialization
Citations

This map shows the geographic impact of Sundeep Dugar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sundeep Dugar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sundeep Dugar more than expected).

Fields of papers citing papers by Sundeep Dugar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sundeep Dugar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sundeep Dugar. The network helps show where Sundeep Dugar may publish in the future.

Co-authorship network of co-authors of Sundeep Dugar

This figure shows the co-authorship network connecting the top 25 collaborators of Sundeep Dugar. A scholar is included among the top collaborators of Sundeep Dugar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sundeep Dugar. Sundeep Dugar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Leo Li‐Ying, Yajie Yin, Wenchuan Sun, et al.. (2021). SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer. Frontiers in Oncology. 10. 624498–624498. 5 indexed citations
2.
Dugar, Sundeep, Francisco Villarreal, Dinesh Mahajan, et al.. (2019). 11-β-hydroxysterols as possible endogenous stimulators of mitochondrial biogenesis as inferred from epicatechin molecular mimicry. Pharmacological Research. 151. 104540–104540. 8 indexed citations
3.
Gutiérrez-Salmeán, Gabriela, Eduardo Meaney, Miguel A. Lanaspa, et al.. (2016). A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects. International Journal of Cardiology. 223. 500–506. 51 indexed citations
4.
Tan, Xuefei, Richland Tester, Gregory R. Luedtke, et al.. (2010). Design and synthesis of piperazine-indole p38α MAP kinase inhibitors with improved pharmacokinetic profiles. Bioorganic & Medicinal Chemistry Letters. 20(3). 828–831. 12 indexed citations
5.
Tester, Richland, Xuefei Tan, Gregory R. Luedtke, et al.. (2010). Amide-based inhibitors of p38α MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides. Bioorganic & Medicinal Chemistry Letters. 20(8). 2560–2563. 2 indexed citations
6.
Luedtke, Gregory R., Xuefei Tan, Richland Tester, et al.. (2010). Amide-based inhibitors of p38α MAP kinase. Part 1: Discovery of novel N-pyridyl amide lead molecules. Bioorganic & Medicinal Chemistry Letters. 20(8). 2556–2559. 10 indexed citations
7.
Mavunkel, Babu, John Perumattam, Xuefei Tan, et al.. (2009). Piperidine-based heterocyclic oxalyl amides as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1059–1062. 21 indexed citations
8.
Levy, Daniel E., Qing Lu, Zheng Chen, et al.. (2008). Aryl–indolyl maleimides as inhibitors of CaMKIIδ. Part 1: SAR of the aryl region. Bioorganic & Medicinal Chemistry Letters. 18(7). 2390–2394. 14 indexed citations
9.
Levy, Daniel E., Qing Lu, Zheng Chen, et al.. (2008). Aryl-indolyl maleimides as inhibitors of CaMKIIδ. Part 2: SAR of the amine tether. Bioorganic & Medicinal Chemistry Letters. 18(7). 2395–2398. 9 indexed citations
10.
Mavunkel, Babu, Yongjin Xu, Bindu Goyal, et al.. (2008). Pyrimidine-based inhibitors of CaMKIIδ. Bioorganic & Medicinal Chemistry Letters. 18(7). 2404–2408. 13 indexed citations
11.
Medicherla, Satyanarayana, Paul Woodman, Ann M. Kapoun, et al.. (2007). p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation. Journal of Pharmacology and Experimental Therapeutics. 324(3). 921–929. 75 indexed citations
12.
Ge, Rongrong, Partha Ray, Edmund C. Lattime, et al.. (2006). Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo. Clinical Cancer Research. 12(14). 4315–4330. 123 indexed citations
13.
Medicherla, Satyanarayana, Ying Jing, Ruban Mangadu, et al.. (2006). A Selective p38α Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis. Journal of Pharmacology and Experimental Therapeutics. 318(1). 132–141. 65 indexed citations
14.
Li, Zhihe, Ying Jing, Irene Kerr, et al.. (2006). Selective inhibition of p38α MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury. American Journal of Physiology-Heart and Circulatory Physiology. 291(4). H1972–H1977. 60 indexed citations
15.
Medicherla, Satyanarayana, Andrew A. Protter, Ying Jing, et al.. (2006). Preventive and Therapeutic Potential of p38α-Selective Mitogen-Activated Protein Kinase Inhibitor in Nonobese Diabetic Mice with Type 1 Diabetes. Journal of Pharmacology and Experimental Therapeutics. 318(1). 99–107. 13 indexed citations
16.
Kirkwood, Keith L., Fei Li, Jaclynn M. Kreider, et al.. (2006). A p38α Selective Mitogen-Activated Protein Kinase Inhibitor Prevents Periodontal Bone Loss. Journal of Pharmacology and Experimental Therapeutics. 320(1). 56–63. 56 indexed citations
17.
Bonniaud, Philippe, Peter J. Margetts, Martin Kolb, et al.. (2004). Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor. American Journal of Respiratory and Critical Care Medicine. 171(8). 889–898. 210 indexed citations
18.
Ge, Rongrong, Kim A. Reiss, David Liu, et al.. (2004). Selective inhibitors of type I receptor kinase block cellular transforming growth factor-β signaling. Biochemical Pharmacology. 68(1). 41–50. 28 indexed citations
19.
Billard, William, Herbert Binch, Gordon Crosby, et al.. (2000). Diphenylsulfone muscarinic antagonists: piperidine derivatives with high m2 selectivity and improved potency. Bioorganic & Medicinal Chemistry Letters. 10(19). 2209–2212. 13 indexed citations
20.
Clader, John W., Joel G. Berger, Robert E. Burrier, et al.. (1995). Substituted (1,2-Diarylethyl)amide Acyl-CoA:Cholesterol Acyltransferase Inhibitors: Effect of Polar Groups on in Vitro and in Vivo Activity. Journal of Medicinal Chemistry. 38(10). 1600–1607. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mui Cheung Breakdown of academic impact, for papers by Ying Sun Breakdown of academic impact, for papers by Xiaojing Shi Breakdown of academic impact, for papers by Xiaohong Shu Breakdown of academic impact, for papers by Mamoru Shoji Breakdown of academic impact, for papers by Si Chen Breakdown of academic impact, for papers by Hao Xie Breakdown of academic impact, for papers by Mariano Redondo‐Horcajo Breakdown of academic impact, for papers by Yhun Yhong Sheen Breakdown of academic impact, for papers by Allan S. Wagman
Rankless by CCL
2026